These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 11830512)
21. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650 [TBL] [Abstract][Full Text] [Related]
22. Growth inhibition of human malignant glioma cells induced by the PI3-K-specific inhibitor. Shingu T; Yamada K; Hara N; Moritake K; Osago H; Terashima M; Uemura T; Yamasaki T; Tsuchiya M J Neurosurg; 2003 Jan; 98(1):154-61. PubMed ID: 12546364 [TBL] [Abstract][Full Text] [Related]
24. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356 [TBL] [Abstract][Full Text] [Related]
25. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703 [TBL] [Abstract][Full Text] [Related]
27. Insulin-induced Drosophila S6 kinase activation requires phosphoinositide 3-kinase and protein kinase B. Lizcano JM; Alrubaie S; Kieloch A; Deak M; Leevers SJ; Alessi DR Biochem J; 2003 Sep; 374(Pt 2):297-306. PubMed ID: 12841848 [TBL] [Abstract][Full Text] [Related]
28. FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis. Bandyopadhyay S; Pai SK; Watabe M; Gross SC; Hirota S; Hosobe S; Tsukada T; Miura K; Saito K; Markwell SJ; Wang Y; Huggenvik J; Pauza ME; Iiizumi M; Watabe K Oncogene; 2005 Aug; 24(34):5389-95. PubMed ID: 15897909 [TBL] [Abstract][Full Text] [Related]
29. PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas. Nakamura JL; Karlsson A; Arvold ND; Gottschalk AR; Pieper RO; Stokoe D; Haas-Kogan DA J Neurooncol; 2005 Feb; 71(3):215-22. PubMed ID: 15735908 [TBL] [Abstract][Full Text] [Related]
30. Differential mechanisms of constitutive Akt/PKB activation and its influence on gene expression in pancreatic cancer cells. Matsumoto J; Kaneda M; Tada M; Hamada J; Okushiba S; Kondo S; Katoh H; Moriuchi T Jpn J Cancer Res; 2002 Dec; 93(12):1317-26. PubMed ID: 12495471 [TBL] [Abstract][Full Text] [Related]
31. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Li DM; Sun H Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15406-11. PubMed ID: 9860981 [TBL] [Abstract][Full Text] [Related]
32. Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells. Tabellini G; Cappellini A; Tazzari PL; FalĂ F; Billi AM; Manzoli L; Cocco L; Martelli AM J Cell Physiol; 2005 Feb; 202(2):623-34. PubMed ID: 15316930 [TBL] [Abstract][Full Text] [Related]
36. Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN. Mourani PM; Garl PJ; Wenzlau JM; Carpenter TC; Stenmark KR; Weiser-Evans MC Circulation; 2004 Mar; 109(10):1299-306. PubMed ID: 14993145 [TBL] [Abstract][Full Text] [Related]
37. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells. Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865 [TBL] [Abstract][Full Text] [Related]
38. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. Yuan ZQ; Sun M; Feldman RI; Wang G; Ma X; Jiang C; Coppola D; Nicosia SV; Cheng JQ Oncogene; 2000 May; 19(19):2324-30. PubMed ID: 10822383 [TBL] [Abstract][Full Text] [Related]
39. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids? Menendez JA; Colomer R; Lupu R Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569 [TBL] [Abstract][Full Text] [Related]